We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Can UNH's Focus on Special Needs Plans Strengthen Medicare Growth?
Read MoreHide Full Article
Key Takeaways
UNH is prioritizing C-SNPs and D-SNPs for 2027 to drive targeted Medicare Advantage growth.
C-SNPs will reach nearly 50M Medicare-eligible individuals, while D-SNPs will cover 74% of dual eligibles.
UNH expects Medicare margins near the upper end of its 2%-4% target in 2026, aided by better cost management.
UnitedHealth Group Incorporated (UNH - Free Report) is refining its Medicare Advantage strategy, emphasizing high-value health maintenance organization (HMO) plans and specialized coverage for seniors with complex healthcare needs. For 2027, UnitedHealthcare plans to prioritize Chronic Special Needs Plans (C-SNPs) and Dual Eligible Special Needs Plans (D-SNPs).
The opportunity is substantial. UnitedHealthcare's C-SNPs will be available to nearly 50 million Medicare-eligible individuals in 2027, offering tailored support for people managing conditions such as diabetes, cardiovascular disease and chronic heart failure. Meanwhile, its D-SNPs will reach approximately 74% of dual-eligible individuals, facilitating coordinated Medicare and Medicaid benefits. These plans can connect members with more coordinated care, medication support and preventive services, potentially creating opportunities to improve outcomes and limit avoidable healthcare spending.
UNH's approach also fits its broader shift toward more selective Medicare Advantage offerings. The company is adjusting plan benefits and market participation to better align coverage with healthcare costs. It expects Medicare margins to approach the upper end of its 2%-4% target range in 2026, reflecting improved cost management and product positioning. Integrated care through Optum Health could further support this strategy by coordinating services for members with complex needs.
Star ratings remain another consideration. UnitedHealthcare reported that at least 69% of its Medicare Advantage members are in plans rated four stars or higher for 2027. UNH's focus on special needs plans could support targeted growth, but execution, medical costs and quality performance can shape the results.
How Are Competitors Faring?
Some of UNH’s major competitors in the healthcare service provider space are Humana Inc. (HUM - Free Report) and Centene Corporation (CNC - Free Report) .
Humana is expanding its Chronic Condition Special Needs Plans into Pennsylvania, Utah and Wisconsin for 2027. HUM’s focus on tailored coverage and coordinated care could attract beneficiaries with complex conditions, while stronger Star Ratings may support its Medicare Advantage competitiveness.
Through its Wellcare brand, Centene is emphasizing affordable Medicare Advantage coverage and integrated care for dual-eligible beneficiaries in 2027. CNC’s coordinated Medicare-Medicaid offerings could strengthen its appeal among members with complex needs, although managing medical expenses remains key.
Shares of UNH have gained 19.5% in the year-to-date period compared with the industry’s rise of 22.9%.
Image Source: Zacks Investment Research
From a valuation standpoint, UnitedHealth trades at a forward price-to-earnings ratio of 18, above the industry average of 15.73. UNH carries a Value Score of A.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for UnitedHealth’s 2026 earnings is pegged at $19.85 per share, implying 21.4% growth from the year-ago period.
View the Zacks #1 Rank List
Image: Bigstock
Can UNH's Focus on Special Needs Plans Strengthen Medicare Growth?
Key Takeaways
UnitedHealth Group Incorporated (UNH - Free Report) is refining its Medicare Advantage strategy, emphasizing high-value health maintenance organization (HMO) plans and specialized coverage for seniors with complex healthcare needs. For 2027, UnitedHealthcare plans to prioritize Chronic Special Needs Plans (C-SNPs) and Dual Eligible Special Needs Plans (D-SNPs).
The opportunity is substantial. UnitedHealthcare's C-SNPs will be available to nearly 50 million Medicare-eligible individuals in 2027, offering tailored support for people managing conditions such as diabetes, cardiovascular disease and chronic heart failure. Meanwhile, its D-SNPs will reach approximately 74% of dual-eligible individuals, facilitating coordinated Medicare and Medicaid benefits. These plans can connect members with more coordinated care, medication support and preventive services, potentially creating opportunities to improve outcomes and limit avoidable healthcare spending.
UNH's approach also fits its broader shift toward more selective Medicare Advantage offerings. The company is adjusting plan benefits and market participation to better align coverage with healthcare costs. It expects Medicare margins to approach the upper end of its 2%-4% target range in 2026, reflecting improved cost management and product positioning. Integrated care through Optum Health could further support this strategy by coordinating services for members with complex needs.
Star ratings remain another consideration. UnitedHealthcare reported that at least 69% of its Medicare Advantage members are in plans rated four stars or higher for 2027. UNH's focus on special needs plans could support targeted growth, but execution, medical costs and quality performance can shape the results.
How Are Competitors Faring?
Some of UNH’s major competitors in the healthcare service provider space are Humana Inc. (HUM - Free Report) and Centene Corporation (CNC - Free Report) .
Humana is expanding its Chronic Condition Special Needs Plans into Pennsylvania, Utah and Wisconsin for 2027. HUM’s focus on tailored coverage and coordinated care could attract beneficiaries with complex conditions, while stronger Star Ratings may support its Medicare Advantage competitiveness.
Through its Wellcare brand, Centene is emphasizing affordable Medicare Advantage coverage and integrated care for dual-eligible beneficiaries in 2027. CNC’s coordinated Medicare-Medicaid offerings could strengthen its appeal among members with complex needs, although managing medical expenses remains key.
UnitedHealth’s Price Performance, Valuation & Estimates
Shares of UNH have gained 19.5% in the year-to-date period compared with the industry’s rise of 22.9%.
Image Source: Zacks Investment Research
From a valuation standpoint, UnitedHealth trades at a forward price-to-earnings ratio of 18, above the industry average of 15.73. UNH carries a Value Score of A.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for UnitedHealth’s 2026 earnings is pegged at $19.85 per share, implying 21.4% growth from the year-ago period.
Image Source: Zacks Investment Research
UNH stock currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.